1.Construction of a regional information system based on standardization and middleware platform.
Jin-xiong CHEN ; Xiong-fei LIU ; Lun YU ; Lin PAN ; Zhi-sheng CHEN ; Hui LIU
Chinese Journal of Medical Instrumentation 2006;30(4):250-252
In this article, based on the analysis on the regional information system's development background and its applications, the construction of the regional medical information system through creating the electronic medical record and the medicine image data centers is proposed, for information resource sharing. And then, the system's software construction and various subsystems functions are mainly introduced. Standardization and the middleware platform are suggested as the effective way of constructing these two data centers in the present situation in our country.
Computer Security
;
Computer Systems
;
Hospital Information Systems
;
Humans
;
Medical Records Systems, Computerized
;
Radiology Information Systems
;
Software
2.Effect of integrin-linked kinase on renal tubular epithelial cell transdifferentiation in diabetic rats.
Jian-Ping NING ; Shen YANG ; Chen NING ; Ying-Hui ZENG ; Lun-Zhi LIU ; Jun LIU
Journal of Central South University(Medical Sciences) 2007;32(1):104-108
OBJECTIVE:
To determine the effect of integrin-linked kinase(ILK) in renal tubular epithelial cells and its relation to tubular epithelial-myofibroblast transdifferentiation.
METHODS:
Wistar rats were randomly divided into 3 groups, Group normal control (n=10), Group diabetic without therapy(n=10) and Group diabetic with Losartan 20mg/(kg . d)(n=10). Five rats were killed in each group at the 8th and 16th week. The left kidneys were kept for HE and Masson staining to observe the pathological variations in the renal interstitium. ILK, alpha-SMA and Vimentin in renal tubular epithelial cells were detected by immunohistochemistry analysis.
RESULTS:
Compared with the control group, ILK, alpha-SMA and Vimentin in renal tubular epithelial cells in Group diabetes gradually increased in immunohistochemistry (P<0.01); ILK was consistent with the pathological variation of renal interstitium and was positively correlated to alpha-SMA(rs=0.621, P<0.05). In comparison with the Group diabetes, the expression of ILK, alpha-SMA and Vimentin in renal tubular epithelial cells was apparently declined (P<0.01) in Group diabetes with Losartan.
CONCLUSION
Tubular epithelial myofibroblast transdifferentiation and the over-expression of ILK, between which there may be significant connections, are important events in the progression of diabetic nephropathy. Losartan, a blocker of angiotension II type I receptor, which may down-regulate the expression of ILK in diabetic renal tubular epithelial cells, can restrain the procession of epithelial-myofibroblast transdifferentiation.
Actins
;
biosynthesis
;
Animals
;
Cell Transdifferentiation
;
Diabetes Mellitus, Experimental
;
drug therapy
;
physiopathology
;
Diabetic Nephropathies
;
drug therapy
;
physiopathology
;
Epithelial Cells
;
drug effects
;
enzymology
;
pathology
;
Fibroblasts
;
drug effects
;
enzymology
;
pathology
;
Immunohistochemistry
;
Kidney Tubules
;
pathology
;
Losartan
;
pharmacology
;
therapeutic use
;
Male
;
Protein-Serine-Threonine Kinases
;
biosynthesis
;
Random Allocation
;
Rats
;
Rats, Wistar
;
Vimentin
;
biosynthesis
4.Sequence Analysis of EBV-BARF0 Gene in Nasopharyngeal Carcinoma from Guangdong Area
Li-Bing SONG ; Yi-Xin ZENG ; Ying-Hong MA ; Qing-Lun LIU ; Man-Zhi LI ; Duan LI ; Hui-Min WANG
Chinese Journal of Cancer 2001;20(5):464-467
Objective: There were variations of EBV genome from different areas and they may affect the biologic function of EBV (such as LMP1). EBV-BARF0 was highly detected in the patients with nasopharyngeal carcinoma(NPC) and it s variations have not been reported. This study was designed to determine the sequence and variation of EBV-BARF0 gene in the patieats with NPC from Guangdong area. Methods: PCR was used to amplify the EBV-BARF0 gene in 20 patients with NPC and the productions were sequenced on the ABI377. Results: Comparing with standard B95-8, there were four loci with variances including: 160473 ( G→ T) , 160545 ( C→ T) , 160701 ( C→ A) , 160707 ( G→ C) of sequences and 2 ( Ala→ Ser) , 26 ( Leu→ Phe) , 78 ( Arg→ Ser) , 80 ( Ala→ Pro) of amino acid in 20 patients with NPC. Conclusion: Since the BARF0 gene of EBV is expressed in all nasopharyngeal carcinoma cell line and biopsies, but it is not expressed or less frequenly in lymphoma tissues and cell lines,the authors firstly reported the variation of EBV-BARF0 which compared with B95-8 in the patieats with NPC from Guangdong area. These suggest that the gene may play an important role in the carcinogenesis and development of nasopharyngeal carcinoma.
5.Receptor antagonist of NMDA and animal models of schizophrenia.
Shi-Zhong BIAN ; Jian ZHANG ; Wei-Li LIU ; Zhi-Hong SUN ; Zhen-Lun GU ; Xiao-Gang JIANG
Journal of Forensic Medicine 2009;25(6):443-446
Schizophrenia is one of the common mental diseases. Because the mechanism of the schizophrenia is significantly complicated, the cause is still unknown. N-methyl-D-aspartate receptor antagonist can simulate the positive and negative symptoms, as well as the cognitive disorder of schizophrenia. Thus it has been widely used to establish the animal models of schizophrenia. The relationship of the three blocking agents of ion channels (phencyclidine, MK-801, ketamine) and the establishment of schizophrenia animal models is reviewed in this article.
Animals
;
Behavior, Animal/drug effects*
;
Brain/physiopathology*
;
Consciousness Disorders/physiopathology*
;
Disease Models, Animal
;
Dizocilpine Maleate/pharmacology*
;
Excitatory Amino Acid Antagonists/pharmacology*
;
Humans
;
Ketamine/pharmacology*
;
Mice
;
Phencyclidine/pharmacology*
;
Rats
;
Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors*
;
Schizophrenia/physiopathology*
6.Evaluation on the role of hepatitis A vaccine in the prevention and control of hepatitis A in Tianjin city.
Zhi-lun ZHANG ; Xiang-jun ZHU ; Ya-xing DING ; Xiao-hua XIE ; Zhi-gang GAO ; Yong-cheng LI ; Ying ZHANG ; Wei-dong XIA ; Yong LIU
Chinese Journal of Epidemiology 2007;28(10):1000-1003
OBJECTIVETo evaluate the effects of prevention and control strategies on hepatitis A.
METHODSSurveillance data on hepatitis A from 1990 to 2006 in Tianjin was analyzed, and the coverage rate of hepatitis A vaccine among targeted population was estimated, to compare the anti-HAV IgG level of children younger than 15 years old in 1999 and in 2005.
RESULTSResults showed that a) the morbidity of hepatitis A decreased from 25.26/10(5) in 1990 to 0.82/10(5) in 2006; b) the ratio of hepatitis A in viral hepatitis decreased from 30.43% in 1990 to 1.05% in 2006; c) the estimated coverage rate was 72.7%; d) the positive rate of anti-HAV among children younger than 15 years old in 2005 was distinctly higher than that in 1999.
CONCLUSIONPositive results showed that it was successful to use hepatitis A vaccine as the strategy to prevent and control hepatitis A in the past five years in Tianjin.
Adolescent ; Child ; Child, Preschool ; China ; epidemiology ; Hepatitis A ; epidemiology ; prevention & control ; Hepatitis A Vaccines ; administration & dosage ; Hepatitis Antibodies ; blood ; Humans ; Immunization Programs ; Incidence ; Infant ; Population Surveillance
7.Epidemiological characteristics of severe acute respiratory syndrome in Tianjin and the assessment of effectiveness on measures of control.
Jie-xiu WANG ; Hong-you FENG ; Dong LIU ; Zhi-lun ZHANG ; Ai-lan SHAN ; Xiang-jun ZHU ; Zhi-gang GAO ; Xu-dong WANG ; Ying-yi XIA ; Qian CHEN
Chinese Journal of Epidemiology 2003;24(7):565-569
OBJECTIVETo analyze the epidemiologic characteristics of severe acute respiratory syndrome (SARS) and to evaluate the effectiveness on its major control measures in Tianjn.
METHODSAdopting two case reports 1 and 2, designed by the Tianjin Centers for Disease Control and Prevention to develop a unified case-tracing table including the map of the distribution of close contacts to SARS patients. With those methods, investigation on patients and their close contacts at hospital wards, families, communities and institutions of the patients were carried out.
RESULTSFrom April 13 through May 8, 2003, there were 175 SARS cases including imported ones, were identified with an incidence rate of 1.9 cases per 100,000. Among them, 14 died with a fatality of 8.0%. The whole process of epidemic in Tianjin was less than one month with the following features: (1) 93.7% of the total SARS cases in Tianjin were directly or indirectly transmitted by a super-spreader. (2) 68.6% of the total SARS patients were concentrated in 3 hospitals A, B and C which was menifastated in 'clustering'. Through study on the rest of the SARS patients, results showed that 16.8% of them were transmitted through family close contact and 2.3% due to contact to colleagues. However, 12.6% of the patients were not able to show evidence that they had any contact to a diagnosed SARS patient. At the early stage of the epidemic, a number of medical practitioners were infected, taking up 38.2% of the total SARS cases. Among the total number of 1 975 medical workers who participated in the SARS medical cares and treatments, 3.4% of them got infected. During the outbreak, all index cases and chains of transmission seemed to be clear, with only 3 patients not able to be traced for the source of infection, taking up 2% of the total SARS patients in Tianjin. Among the 10 index cases, only the super spreader and another one index case transmitted the virus to their contacts but the rest of index cases did not cause any secondary infection.
CONCLUSIONThough SARS is clinically severe and can be spreaded quickly, the epidemic can be under control within a short period of time if chains of SARS transmission are broken down and effective measures as isolation and quarantine against patients as well as underscoring awareness among the publics in a scientific way, being carried out.
Adolescent ; Adult ; Aged ; China ; epidemiology ; Contact Tracing ; Cross Infection ; transmission ; Disease Outbreaks ; Family Health ; Female ; Humans ; Incidence ; Infectious Disease Transmission, Patient-to-Professional ; Male ; Middle Aged ; Severe Acute Respiratory Syndrome ; epidemiology ; mortality ; transmission ; Surveys and Questionnaires
8.Monocarboxylate transporter 1 enhances the sensitivity of breast cancer cells to 3-bromopyruvate in vitro.
Qi-Xiang LI ; Pei ZHANG ; Fang LIU ; Xian-Zhi WANG ; Lu LI ; Zhong-Kun WANG ; Chen-Chen JIANG ; Hai-Lun ZHENG ; Hao LIU
Journal of Southern Medical University 2017;37(5):588-593
OBJECTIVETo investigate the role of monocarboxylate transporter 1 (MCT1) in enhancing the sensitivity of breast cancer cells to 3-bromopyruvate (3-BrPA).
METHODSThe inhibitory effect of 3-BrPA on the proliferation of breast cancer cells was assessed with MTT assay, and brominated propidium bromide single staining flow cytometry was used for detecting the cell apoptosis. An ELISA kit was used to detect the intracellular levels of hexokinase II, lactate dehydrogenase, lactate, and adenosine triphosphate, and Western blotting was performed to detect the expression of MCT1. MDA-MB-231 cells were transiently transfected with MCT1 cDNA for over-expressing MCT1, and the effect of 3-BrPA on the cell proliferation and adenosine triphosphate level was deteced.
RESULTS3-BrPA did not produce significant effects on the proliferation and apoptosis of MDA-MB-231 cells, and the cells treated with 200 µmol/L 3-BrPA for 24 h showed an inhibition rate and an apoptosis rate of only 8.72% and 7.8%, respectively. The same treatment, however, produced an inhibition rate and an apoptosis rate of 84.6% and 82.3% in MCF-7 cells, respectively. In MDA-MB-231 cells with MCT1 overexpression, 200 µmol/L 3-BrPA resulted in an inhibition rate of 72.44%, significantly higher than that in the control cells (P<0.05); treatment of the cells with 25, 50, 100, and 200 µmol/L 3-BrPA for 6 h resulted in intracellular adenosine triphosphate levels of 96.98%, 88.44%, 43.3% and 27.56% relative to the control level respectively.
CONCLUSIONMCT1 can enhance the sensitivity of breast cancer cells to 3-BrPA possibly by transporting 3-BrPA into cells to inhibit cell glycolysis.
9.SiRNA targeting ICP4 attenuates HSV-1 replication.
Yu-tao LIU ; Bo SONG ; Ya-lun WANG ; Yu-ming XU ; Zhi-qiang HAN ; Xin-yu ZHAO ; Li-jie JIA
Chinese Journal of Virology 2010;26(3):163-169
HSV-1, a neurotropic virus, always leads to severe nervous symptoms. It is hard to completely eradicate the latent viruses after conventional therapy so that recurrence is inevitable. ICP is a key regulator for HSV replication and transcription that determines the cytolytic infection or latent state. In search of new anti-virus strategy targeting HSV-1ICP4, two pairs of siRNA were designed, and a recombinant eukaryotic lentiviral expression plasmid pLKO-puro(r)-hU6-siRNA was constructed. Vero cells were transfected with the designed siRNAs by Lipofectamine 2000 and four stable monoclonal cell lines were established by puromycin screening method. The ICP4 expression at mRNA level was detected with real-time PCR, and the HSV-1 replication was measured with TCID50 assay. SiRNA was shown as an effective way to inhibit the expression of ICP4 in monoclonal cell lines. Meanwhile, HSV-1 replication was significantly inhibited when ICP4 was shut down by siRNA. We conclude that siRNA targeting ICP4 attenuates HSV-1 replication. Further more, multi-site siRNAs show stronger inhibitory effect on viral replication, which may be an effective and feasible approach for biological anti-viral drugs.
Animals
;
Base Sequence
;
Cercopithecus aethiops
;
Genetic Therapy
;
Genetic Vectors
;
genetics
;
Herpesvirus 1, Human
;
physiology
;
Humans
;
Immediate-Early Proteins
;
deficiency
;
genetics
;
RNA Interference
;
RNA, Messenger
;
genetics
;
metabolism
;
RNA, Small Interfering
;
genetics
;
Vero Cells
;
Virus Replication
;
genetics